10-Q Filing

CVS HEALTH CORP CIK: 64803 Q2 2019

Filing Information

Form Type	10-Q
Accession Number	`0000064803-19-000039`
Period End Date	20190630
Filing Date	20190807
Fiscal Year	2019
Fiscal Period	Q2
XBRL Instance	a0630201910-q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 102 Income Statement 108 Cash Flow Statement 86 Stockholders Equity 55 Comprehensive Income 34

Balance Sheet 102 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	100,000.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$6.06B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.06B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Investments	`ShortTermInvestments`	$2.46B	USD	Point-in-time
Investments	`ShortTermInvestments`	$2.52B	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$17.63B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Accounts receivable, net	`AccountsReceivableNetCurrent`	$18.17B	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Inventories	`InventoryNet`	$16.45B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	3.20B	shares	Point-in-time
Inventories	`InventoryNet`	$15.51B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.72B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.58B	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	1.72B	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$4.69B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$46.90B	USD	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.30B	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	1.29B	shares	Point-in-time
Total current assets	`AssetsCurrent`	$45.24B	USD	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Treasury stock (in shares)	`TreasuryStockShares`	425.00M	shares	Point-in-time
Long-term investments	`LongTermInvestments`	$15.73B	USD	Point-in-time
Long-term investments	`LongTermInvestments`	$16.97B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.48B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$11.35B	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	-	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.86B	USD	Point-in-time
Goodwill	`Goodwill`	$78.68B	USD	Point-in-time
Goodwill	`Goodwill`	$79.48B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$34.16B	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$36.52B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$3.88B	USD	Point-in-time
Separate accounts assets	`SeparateAccountAssets`	$4.27B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$4.76B	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.05B	USD	Point-in-time
Total assets	`Assets`	$196.46B	USD	Point-in-time
Total assets	`Assets`	$218.90B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$8.93B	USD	Point-in-time
Accounts payable	`AccountsPayableTradeCurrent`	$9.16B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$11.94B	USD	Point-in-time
Pharmacy claims and discounts payable	`PharmacyClaimsandDiscountsPayableCurrent`	$11.37B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.89B	USD	Point-in-time
Health care costs payable	`LiabilityForUnpaidClaimsAndClaimsAdjustmentExpenseNet`	$6.15B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.94B	USD	Point-in-time
Policyholders funds	`OtherPolicyholderFunds`	$2.91B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.56B	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$10.71B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.94B	USD	Point-in-time
Other insurance liabilities	`OtherInsuranceLiabilitiesCurrent`	$1.79B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$1.79B	USD	Point-in-time
Current portion of operating lease liabilities	`OperatingLeaseLiabilityCurrent`	-	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$446.00M	USD	Point-in-time
Short-term debt	`ShortTermBorrowings`	$720.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$1.26B	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$3.89B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$49.38B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$44.01B	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	-	USD	Point-in-time
Long-term operating lease liabilities	`OperatingLeaseLiabilityNoncurrent`	$18.85B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$71.44B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$66.94B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.38B	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxLiabilitiesNet`	$7.68B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$4.27B	USD	Point-in-time
Separate accounts liabilities	`SeparateAccountsLiability`	$3.88B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$7.96B	USD	Point-in-time
Other long-term insurance liabilities	`OtherInsuranceLiabilitiesNoncurrent`	$8.12B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.53B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.78B	USD	Point-in-time
Total liabilities	`Liabilities`	$157.31B	USD	Point-in-time
Total liabilities	`Liabilities`	$137.91B	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.01: 0.1 shares authorized; none issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,724 shares issued and 1,299 shares outstanding at June 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.72B	USD	Point-in-time
Common stock, par value $0.01: 3,200 shares authorized; 1,724 shares issued and 1,299 shares outstanding at June 30, 2019 and 1,720 shares issued and 1,295 shares outstanding at December 31, 2018 and capital surplus	`CommonStocksIncludingAdditionalPaidInCapital`	$45.44B	USD	Point-in-time
Treasury stock, at cost: 425 shares at June 30, 2019 and December 31, 2018	`TreasuryStockValue`	$28.23B	USD	Point-in-time
Treasury stock, at cost: 425 shares at June 30, 2019 and December 31, 2018	`TreasuryStockValue`	$28.26B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$43.14B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$40.91B	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$684.00M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$102.00M	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$61.28B	USD	Point-in-time
Total CVS Health shareholders equity	`StockholdersEquity`	$58.23B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$317.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$318.00M	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Total shareholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$218.90B	USD	Point-in-time
Total liabilities and shareholders equity	`LiabilitiesAndStockholdersEquity`	$196.46B	USD	Point-in-time

Income Statement 108 line items

Line Item	Tag	Value	Unit	Period
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$63.14B	USD	1 Quarter
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$46.71B	USD	1 Quarter
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$92.40B	USD	2 Qtrs
Revenues from customers	`RevenueFromContractWithCustomerExcludingAssessedTax`	$124.53B	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$542.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$214.00M	USD	1 Quarter
Net investment income	`NetInvestmentIncome`	$264.00M	USD	2 Qtrs
Net investment income	`NetInvestmentIncome`	$293.00M	USD	1 Quarter
Total revenues	`Revenues`	$125.08B	USD	2 Qtrs
Total revenues	`Revenues`	$63.43B	USD	1 Quarter
Total revenues	`Revenues`	$46.92B	USD	1 Quarter
Total revenues	`Revenues`	$92.67B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$76.38B	USD	2 Qtrs
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.88B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$38.97B	USD	1 Quarter
Cost of products sold	`CostOfGoodsAndServicesSold`	$76.22B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$631.00M	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$26.55B	USD	2 Qtrs
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$13.09B	USD	1 Quarter
Benefit costs	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$1.96B	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$8.04B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$16.29B	USD	2 Qtrs
Operating expenses	`OperatingExpenses`	$4.87B	USD	1 Quarter
Operating expenses	`OperatingExpenses`	$9.78B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$119.06B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$48.30B	USD	1 Quarter
Total operating costs	`CostsAndExpenses`	$92.04B	USD	2 Qtrs
Total operating costs	`CostsAndExpenses`	$60.10B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$623.00M	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$6.02B	USD	2 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$-1.37B	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$3.33B	USD	1 Quarter
Interest expense	`InterestExpense`	$689.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.21B	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.55B	USD	2 Qtrs
Interest expense	`InterestExpense`	$772.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$31.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$-3.00M	USD	1 Quarter
Other expense (income)	`OtherNonoperatingIncomeExpense`	$62.00M	USD	2 Qtrs
Other expense (income)	`OtherNonoperatingIncomeExpense`	$-6.00M	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-595.00M	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-2.06B	USD	1 Quarter
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$4.53B	USD	2 Qtrs
Income (loss) before income tax provision	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.59B	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$1.17B	USD	2 Qtrs
Income tax provision	`IncomeTaxExpenseBenefit`	$660.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$497.00M	USD	1 Quarter
Income tax provision	`IncomeTaxExpenseBenefit`	$969.00M	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-1.56B	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$-2.56B	USD	1 Quarter
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$3.36B	USD	2 Qtrs
Income (loss) from continuing operations	`IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest`	$1.93B	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	2 Qtrs
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	-	USD	1 Quarter
Loss from discontinued operations, net of tax	`IncomeLossFromDiscontinuedOperationsNetOfTax`	$-1.00M	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.36B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.93B	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$1.94B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-2.56B	USD	1 Quarter
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$3.36B	USD	2 Qtrs
Net income (loss) attributable to CVS Health	`NetIncomeLoss`	$-1.56B	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-1.54	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$1.49	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$-2.52	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, basic (in dollars per share)	`IncomeLossFromContinuingOperationsPerBasicShare`	$2.58	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health, basic (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerBasicShare`	-	USD	1 Quarter
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$-1.54	USD	2 Qtrs
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$-2.52	USD	1 Quarter
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$1.49	USD	1 Quarter
Net income (loss) attributable to CVS Health, basic (in dollars per share)	`EarningsPerShareBasic`	$2.58	USD	2 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.02B	shares	2 Qtrs
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	1 Quarter
Weighted average shares outstanding, basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	1.30B	shares	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-2.52	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$1.49	USD	1 Quarter
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$2.58	USD	2 Qtrs
Income (loss) from continuing operations attributable to CVS Health, diluted (in dollars per share)	`IncomeLossFromContinuingOperationsPerDilutedShare`	$-1.54	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	1 Quarter
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	2 Qtrs
Loss from discontinued operations attributable to CVS Health, diluted (in dollars per share)	`DiscontinuedOperationIncomeLossFromDiscontinuedOperationNetOfTaxPerDilutedShare`	-	USD	2 Qtrs
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-1.54	USD	2 Qtrs
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.58	USD	2 Qtrs
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.49	USD	1 Quarter
Net income (loss) attributable to CVS Health, diluted (in dollars per share)	`EarningsPerShareDiluted`	$-2.52	USD	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	2 Qtrs
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.02B	shares	1 Quarter
Weighted average shares outstanding, diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.30B	shares	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$0.50	USD	1 Quarter
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs
Dividends declared per share (in dollars per share)	`CommonStockDividendsPerShareDeclared`	$1.00	USD	2 Qtrs

Cash Flow Statement 86 line items

Line Item	Tag	Value	Unit	Period
Cash receipts from customers	`ProceedsFromCustomers`	$87.98B	USD	2 Qtrs
Cash receipts from customers	`ProceedsFromCustomers`	$120.81B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$70.76B	USD	2 Qtrs
Cash paid for inventory and prescriptions dispensed by retail network pharmacies	`PaymentsforInventoryandPrescriptionsDispensedbyRetailNetworkPharmacies`	$70.57B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$25.99B	USD	2 Qtrs
Insurance benefits paid	`PaymentsforInsuranceBenefits`	$1.74B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$14.50B	USD	2 Qtrs
Cash paid to other suppliers and employees	`PaymentsToSuppliersAndEmployees`	$8.47B	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$512.00M	USD	2 Qtrs
Interest and investment income received	`ProceedsFromInterestAndDividendsReceived`	$194.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$560.00M	USD	2 Qtrs
Interest paid	`InterestPaidNet`	$1.50B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.35B	USD	2 Qtrs
Income taxes paid	`IncomeTaxesPaidNet`	$1.48B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.29B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.29B	USD	2 Qtrs
Purchases of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$3.79B	USD	2 Qtrs
Purchases of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$37.00M	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$4.06B	USD	2 Qtrs
Purchases of investments	`PaymentsToAcquireInvestments`	$53.00M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.29B	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$912.00M	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$556.00M	USD	2 Qtrs
Acquisitions (net of cash acquired)	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$250.00M	USD	2 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	-	USD	2 Qtrs
Proceeds from sale of subsidiary	`ProceedsFromDivestitureOfBusinessesNetOfCashDivested`	$725.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-14.00M	USD	2 Qtrs
Other	`PaymentsForProceedsFromOtherInvestingActivities`	$-7.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-752.00M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.80B	USD	2 Qtrs
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-1.28B	USD	2 Qtrs
Net repayments of short-term debt	`ProceedsFromRepaymentsOfShortTermDebt`	$-275.00M	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$39.38B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.90B	USD	2 Qtrs
Repayments of long-term debt	`RepaymentsOfLongTermDebt`	$1.00M	USD	2 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	$-446.00M	USD	2 Qtrs
Derivative settlements	`PaymentsForProceedsFromDerivativeInstrumentFinancingActivities`	-	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.02B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$1.31B	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$111.00M	USD	2 Qtrs
Proceeds from exercise of stock options	`ProceedsFromStockOptionsExercised`	$130.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$37.00M	USD	2 Qtrs
Payments for taxes related to net share settlement of equity awards	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$80.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	-	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$7.00M	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$37.62B	USD	2 Qtrs
Net cash provided by (used in) financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-3.44B	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$42.16B	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$2.04B	USD	2 Qtrs
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.06B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the beginning of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$44.06B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.34B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.29B	USD	Point-in-time
Cash, cash equivalents and restricted cash at the end of the period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$1.90B	USD	Point-in-time
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.36B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.93B	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.29B	USD	2 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$2.18B	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	1 Quarter
Goodwill impairment	`GoodwillImpairmentLoss`	$3.92B	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	2 Qtrs
Goodwill impairment	`GoodwillImpairmentLoss`	-	USD	1 Quarter
Deferred income taxes and other noncash items	`ShareBasedCompensation`	$226.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`ShareBasedCompensation`	$110.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$-42.00M	USD	2 Qtrs
Deferred income taxes and other noncash items	`Deferredincometaxesandothernoncashitems`	$252.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$681.00M	USD	2 Qtrs
Accounts receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.06B	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-939.00M	USD	2 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-369.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$314.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$174.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$917.00M	USD	2 Qtrs
Accounts payable and pharmacy claims and discounts payable	`IncreaseDecreaseInAccountsPayable`	$1.04B	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$224.00M	USD	2 Qtrs
Health care costs payable and other insurance liabilities	`IncreaseDecreaseInInsuranceLiabilities`	$496.00M	USD	2 Qtrs
Reconciliation of net income (loss) to net cash provided by operating activities:	`IncreaseDecreaseInOtherOperatingLiabilities`	$875.00M	USD	2 Qtrs
Reconciliation of net income (loss) to net cash provided by operating activities:	`IncreaseDecreaseInOtherOperatingLiabilities`	$204.00M	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$5.29B	USD	2 Qtrs
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$7.29B	USD	2 Qtrs

Stockholders Equity 55 line items

Line Item	Tag	Value	Unit	Period
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury Shares Held in Trust (in shares)	`TreasuryStockSharesHeldinTrust`	1.00M	shares	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$29.00M	USD	Point-in-time
Treasury shares held in trust value	`TreasuryStockValueSharesHeldInTrust`	$31.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Common stock par value	`CommonStockValue`	$17.00M	USD	Point-in-time
Adoption of new accounting standard	`CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption`	$-13.00M	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Balance at beginning of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.93B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$1.43B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-2.56B	USD	1 Quarter
Net income (loss)	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$998.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$582.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$313.00M	USD	2 Qtrs
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$73.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$104.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$112.00M	USD	1 Quarter
Stock option activity, stock awards and other	`StockIssuedDuringPeriodValueStockOptionsExercised`	$175.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$33.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$36.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-7.00M	USD	1 Quarter
Purchase of treasury shares, net of ESPP issuances	`TreasuryStockValueAcquiredCostMethodNetOfESPPIssuance`	$-49.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$508.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$651.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$512.00M	USD	1 Quarter
Common stock dividends	`DividendsCommonStock`	$659.00M	USD	1 Quarter
Other decreases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$4.00M	USD	1 Quarter
Other decreases in noncontrolling interests	`NoncontrollinginterestOtherPeriodIncreaseDecrease`	$-2.00M	USD	1 Quarter
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$35.61B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$58.54B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$60.01B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$38.68B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$37.70B	USD	Point-in-time
Balance at end of period	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$61.60B	USD	Point-in-time

Comprehensive Income 34 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`ProfitLoss`	$-2.56B	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$3.36B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$-1.56B	USD	2 Qtrs
Net income (loss)	`ProfitLoss`	$1.93B	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$585.00M	USD	2 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	$251.00M	USD	1 Quarter
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	2 Qtrs
Net unrealized investment gains	`OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent`	-	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$4.00M	USD	2 Qtrs
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-27.00M	USD	1 Quarter
Foreign currency translation adjustments	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-3.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-7.00M	USD	2 Qtrs
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-4.00M	USD	1 Quarter
Net cash flow hedges	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$339.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$251.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$331.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$344.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-31.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$582.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$313.00M	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-1.25B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$3.94B	USD	2 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-2.59B	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$2.18B	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Comprehensive (income) loss attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-5.00M	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$3.94B	USD	2 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-1.25B	USD	2 Qtrs
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$2.19B	USD	1 Quarter
Comprehensive income (loss) attributable to CVS Health	`ComprehensiveIncomeNetOfTax`	$-2.59B	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.